Shawver Laura's Form 4 filing
ARS Pharmaceuticals, Inc. (SPRY) · filed Mar 7, 2025
- Accession no.
- 0001415889-25-007438
- Filed
- Mar 7, 2025
- Trade date
- Mar 5-6, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $560.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shawver LauraCIK 0001551891 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | Common Stock | MOption exerciseAcquired | +400 | $4.85 | +$1,940 | 210,746 | Direct | |
| Mar 5, 2025 | Common Stock | SSaleDisposed | −400 | $11.00 | −$4,400 | 210,346 | Direct | |
| Mar 6, 2025 | Common Stock | MOption exerciseAcquired | +49,600 | $4.85 | +$240,560 | 259,946 | Direct | |
| Mar 6, 2025 | Common Stock | SSaleDisposed | −49,600 | $11.21 | −$556,016 | 210,346 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | Common Stock | MOption exerciseDisposed | −400 | $0.00 | $0 | 123,664 | Direct | |
| Mar 6, 2025 | Common Stock | MOption exerciseDisposed | −49,600 | $0.00 | $0 | 74,064 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.